Malcomson Fiona C, Willis Naomi D, McCallum Iain, Xie Long, Lagerwaard Bart, Kelly Seamus, Bradburn D Michael, Belshaw Nigel J, Johnson Ian T, Mathers John C
Human Nutrition Research Centre, Institute of Cellular Medicine, Newcastle University, Campus for Ageing and Vitality, Newcastle upon Tyne, UK.
Northumbria Healthcare NHS Foundation Trust, North Shields, UK.
Mol Carcinog. 2017 Sep;56(9):2104-2111. doi: 10.1002/mc.22666. Epub 2017 May 9.
Colorectal cancer (CRC) risk is modulated by diet and there is convincing evidence of reduced risk with higher non-digestible carbohydrates (NDCs) consumption. Resistant starch (RS), a NDC, positively modulates the expression of oncogenic microRNAs, suggesting that this could be a mechanism through which NDCs protect against CRC. The present study aimed to investigate the effects of supplementation with two NDCs, RS, and polydextrose (PD), on microRNA expression in the macroscopically-normal human rectal epithelium using samples from the DISC Study, a randomized, double-blind, placebo-controlled dietary intervention. We screened 1008 miRNAs in pooled post-intervention rectal mucosal samples from participants allocated to the double placebo group and those supplemented with both RS and PD. A total of 111 miRNAs were up- or down-regulated by at least twofold in the RS + PD group compared with the control group. From these, eight were selected for quantification in individual participant samples by qPCR, and fold-change direction was consistent with the array for seven miRNAs. The inconsistency for miR-133b and the lower fold-change values observed for the seven miRNAs is probably because qPCR of individual participant samples is a more robust and sensitive method of quantification than the array. miR-32 expression was increased by approximately threefold (P = 0.033) in the rectal mucosa of participants supplemented with RS + PD compared with placebo. miR-32 is involved in the regulation of processes such as cell proliferation that are dysregulated in CRC. Furthermore, miR-32 may affect non-canonical NF-κB signaling via regulation of TRAF3 expression and consequently NIK stabilization.
结直肠癌(CRC)风险受饮食调节,有确凿证据表明,食用更多的非消化性碳水化合物(NDC)可降低风险。抗性淀粉(RS)作为一种NDC,可正向调节致癌性微小RNA的表达,这表明这可能是NDC预防CRC的一种机制。本研究旨在利用DISC研究(一项随机、双盲、安慰剂对照的饮食干预研究)中的样本,调查补充两种NDC(RS和聚葡萄糖(PD))对宏观正常的人类直肠上皮中微小RNA表达的影响。我们在分配至双安慰剂组以及同时补充RS和PD的参与者干预后的直肠黏膜混合样本中筛选了1008种微小RNA。与对照组相比,RS + PD组共有111种微小RNA上调或下调至少两倍。从中选择了8种通过qPCR在个体参与者样本中进行定量,7种微小RNA的倍数变化方向与芯片结果一致。miR-133b的不一致以及7种微小RNA观察到的较低倍数变化值可能是因为个体参与者样本的qPCR是一种比芯片更可靠、更灵敏的定量方法。与安慰剂相比,补充RS + PD的参与者直肠黏膜中miR-32表达增加了约三倍(P = 0.033)。miR-32参与细胞增殖等在CRC中失调的过程的调节。此外,miR-32可能通过调节TRAF3表达进而稳定NIK来影响非经典NF-κB信号传导。